The 6th Cell and Gene Patient Engagement Therapy Summit explores innovative strategies to enhance patient engagement, education, and advocacy in cell and gene therapy development and delivery.
Key Topics
Understanding how to optimize the collaboration between patient engagement and clinical operations to recruit and retain ideal cohort
Evaluating best practice for patient engagement and advocacy for effective and patient centric collaboration
Exploring the innovative methods of cell and gene therapy education to improve patient awareness
Demonstrating new digital education tools for CAR-T to support shared decision making in cell therapy
Learning how to create a coalition to cultivate state policy change
Collaborating with patient groups to tell the right story to payers and insurance companies
Integrating methods for early patient participation to optimize for a patient-therapy fit
Maximizing patient education and collaboration during research and development to support patient preparation to receive a therapy
Utilizing patient involvement to achieve regulatory approval
Driving for better patient experience throughout patient journey to optimize for patient retention
Audience workshop: spearheading new approaches in quantifying cell and gene therapy patient engagement to showcase patient engagement’s critical value
Understanding the differences between prevalent and rare diseases to optimize tailored patient educational materials
Exploring the value of patients voices to inform the development process and future probability of therapeutic access
Parent interview session: exploring how patients decide on joining cell and gene clinical trials to optimize for better decision-making tools
Debating whether patient organization leaders should be involved in regulatory meetings to optimize patient transparency
Addressing the practical needs of patients during long-term follow ups to ensure patient retention
Investigating new strategies using patient voices to increase therapeutic access
Optimizing healthcare readiness and treatment experiences to assist patients throughout treatment journey
Who should Attend
Patient advocacy leaders
Clinical operations professionals
Biotech and pharma executives in cell and gene therapy
